| Subject: | CDC Changes Recommendations for Gonorrhea Treatment |
| Category: | Centers for Disease Control and Prevention (CDC)
|
| Published: | Tue, 17 Apr 2007 - 12:00 am |
| The CDC has changed its recommendations for treatment of gonorrhea due to drug resistance. The CDC no longer recommends antibiotics known as fluoroquinolones (ciprofloxacin, ofloxacin, and levofloxacin) as a treatment for gonorrhea in the United States, which limits the options available to treat gonorrhea, one of the most common sexually transmitted diseases in the United States.
New data released in the CDC’s April 12, 2007 Morbidity and Mortality Weekly Report (MMWR) showed that... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
External Links:
|
|
With over 20 years experience in regulatory compliance, MCN Healthcare brings you the most comprehensive regulatory compliance tool available. StayAlert! is the only comprehensive e-mail notification service available that not only notifies you of the changes in major federal regulations, but also provides the policies, procedures, tools and best practices to help you meet the changing regulation. StayAlert! actively monitors TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others so you don't have to. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|
